Name: ABSA’s 1st Biosecurity Symposium
Start: 2021-04-20T00:00:00-05:00
End: 2021-04-23T23:59:59-05:00
Location: Renaissance Depot Hotel

The Response Measures Database: Central Archive of COVID-19 Interventions

EU Initiative on Health Security Work Programme 2021

Dr. Fauci Makes First Appearance at Biden White House Press Briefing – Transcript

by Global Biodefense Staff January 21, 2021, 8:42 pm
ASM Expresses Support for the Global Health Security Act of 2021

by Global Biodefense Staff January 21, 2021, 6:28 pm
Hepatitis D: How the Virus Made the Jump From Animals to Humans

by Laura Bergner and Daniel Streicker January 18, 2021, 6:52 pm
Vaccine Delays Reveal Weak Link in Supply Chains: A Shortage of Workers

by Anna Nagurney January 8, 2021, 12:53 pm
Heading Off The Next Pandemic

by Jim Robbins, KHN January 4, 2021, 10:15 am
At Risk of Extinction, Black-Footed Ferrets Get Experimental COVID Vaccine

by JoNel Aleccia, Kaiser Health News December 23, 2020, 12:36 pm
Building Safeguards for Genetically Engineered Microbes

by Global Biodefense Staff November 13, 2020, 1:29 pm
Inside the Lab: How Do Coronavirus Researchers Avoid Catching COVID-19?

by Grace C. Roberts October 19, 2020, 9:47 pm
The ‘One Health’ Concept Must Prevail to Allow Us to Prevent Pandemics

by Eric Muraille and Jacques Godfroid October 19, 2020, 9:22 pm
Draft Policy Issued for Large Animal Outdoor Containment Select Agent Studies

by Global Biodefense Staff October 19, 2020, 4:43 pm
Newsletter

Global Biodefense News

First Name

Last Name

Organization Type

Email address:

Don't worry, we don't spam
CRDF Global Selected to Support Biological Threat Reduction Program Contracts

by Global Biodefense Staff October 19, 2020, 4:06 pm
Validated Methods for Removing Select Agent Samples from BSL-3 Labs

by Global Biodefense Staff October 19, 2020, 3:36 pm
Securing Synthetic Biology Data At Risk During the COVID-19 Pandemic

by Global Biodefense Staff October 13, 2020, 6:14 pm
Talc and Petroleum Jelly Top List of Skin Protectants for Frontline Responders Wearing PPE

by Global Biodefense Staff September 25, 2020, 5:39 pm

Congratulations. You've reached the end of the internet.

Biosecurity

The Response Measures Database: Central Archive of COVID-19 Interventions

EU Initiative on Health Security Work Programme 2021

Dr. Fauci Makes First Appearance at Biden White House Press Briefing – Transcript

ASM Expresses Support for the Global Health Security Act of 2021

Hepatitis D: How the Virus Made the Jump From Animals to Humans

Vaccine Delays Reveal Weak Link in Supply Chains: A Shortage of Workers

Heading Off The Next Pandemic

At Risk of Extinction, Black-Footed Ferrets Get Experimental COVID Vaccine

Building Safeguards for Genetically Engineered Microbes

Inside the Lab: How Do Coronavirus Researchers Avoid Catching COVID-19?

The ‘One Health’ Concept Must Prevail to Allow Us to Prevent Pandemics

Draft Policy Issued for Large Animal Outdoor Containment Select Agent Studies

CRDF Global Selected to Support Biological Threat Reduction Program Contracts

Validated Methods for Removing Select Agent Samples from BSL-3 Labs

Securing Synthetic Biology Data At Risk During the COVID-19 Pandemic

Talc and Petroleum Jelly Top List of Skin Protectants for Frontline Responders Wearing PPE

Biodefense Headlines – 21 January 2021

First Cases of B.1.1.7 Variant COVID-19 Detected in Washington State

The Response Measures Database: Central Archive of COVID-19 Interventions

EU Initiative on Health Security Work Programme 2021

Rapid Identification of Ricin in Serum Samples Using LC–MS/MS

Dr. Fauci Makes First Appearance at Biden White House Press Briefing – Transcript

ASM Expresses Support for the Global Health Security Act of 2021

How and When Will Lower-Income Countries Gain Access to COVID-19 Vaccines?

OHDSI Awarded $10M FDA Contract to Monitor Safety and Effectiveness of Vaccines, Biologics

Neutralizing Norovirus: NIAID Monoclonal Antibodies Licensing Opportunity

NIAID Looks Ahead to Pan-Coronavirus Vaccine Candidates

DRIVE ReDIRECT: Program Seeks to Develop Countermeasures Against Chemical Threats

Emerging Infections Network – Managing Travelers Who Acquire Disease Abroad

Upcoming Events

Application Deadline: Expanding Existing Research Grants, CRADAs for Novel Coronavirus Response

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 2

Systematizing the One Health Approach in Preparedness and Response Efforts for Infectious Disease Outbreaks

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 3

ABSA’s 1st Biosecurity Symposium

Latest stories

Latest Articles